- Home
- Publications
- Publication Search
- Publication Details
Title
Targeted Agents in Cervical Cancer: Beyond Bevacizumab
Authors
Keywords
-
Journal
Current Oncology Reports
Volume 20, Issue 5, Pages -
Publisher
Springer Nature
Online
2018-04-02
DOI
10.1007/s11912-018-0680-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Safety and Clinical Activity of the Programmed Death-Ligand 1 Inhibitor Durvalumab in Combination With Poly (ADP-Ribose) Polymerase Inhibitor Olaparib or Vascular Endothelial Growth Factor Receptor 1-3 Inhibitor Cediranib in Women's Cancers: A Dose-Escalation, Phase I Study
- (2017) Jung-Min Lee et al. JOURNAL OF CLINICAL ONCOLOGY
- Characterization of the Anti–PD-1 Antibody REGN2810 and Its Antitumor Activity in Human PD-1 Knock-In Mice
- (2017) Elena Burova et al. MOLECULAR CANCER THERAPEUTICS
- Advances and Concepts in Cervical Cancer Trials
- (2016) Satoru Sagae et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Phase 2 Randomized Controlled Trial of Radiation Therapy Plus Concurrent Interferon-Alpha and Retinoic Acid Versus Cisplatin for Stage III Cervical Carcinoma
- (2016) Partha Basu et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Compensatory upregulation of PD-1, LAG-3, and CTLA-4 limits the efficacy of single-agent checkpoint blockade in metastatic ovarian cancer
- (2016) Ruea-Yea Huang et al. OncoImmunology
- Antiangiogenic agents in gynecological cancer: State of art and perspectives of clinical research
- (2015) Angiolo Gadducci et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Immunotherapy and targeted therapy for cervical cancer: an update
- (2015) Gulden Menderes et al. Expert Review of Anticancer Therapy
- A Phase I-II Evaluation of Veliparib (NSC #737664), Topotecan, and Filgrastim or Pegfilgrastim in the Treatment of Persistent or Recurrent Carcinoma of the Uterine Cervix
- (2015) Charles Kunos et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Paclitaxel Plus Carboplatin Versus Paclitaxel Plus Cisplatin in Metastatic or Recurrent Cervical Cancer: The Open-Label Randomized Phase III Trial JCOG0505
- (2015) Ryo Kitagawa et al. JOURNAL OF CLINICAL ONCOLOGY
- Complete Regression of Metastatic Cervical Cancer After Treatment With Human Papillomavirus–Targeted Tumor-Infiltrating T Cells
- (2015) Sanja Stevanović et al. JOURNAL OF CLINICAL ONCOLOGY
- Cediranib combined with carboplatin and paclitaxel in patients with metastatic or recurrent cervical cancer (CIRCCa): a randomised, double-blind, placebo-controlled phase 2 trial
- (2015) R Paul Symonds et al. LANCET ONCOLOGY
- The biology and treatment of oligometastatic cancer
- (2015) Diane K. Reyes et al. Oncotarget
- Tumor-associated macrophages induce lymphangiogenesis in cervical cancer via interaction with tumor cells
- (2014) Hui Ding et al. APMIS
- Phase 2 Trial of Paclitaxel, 13-cis Retinoic Acid, and Interferon Alfa-2b in the Treatment of Advanced Stage or Recurrent Cervical Cancer
- (2014) Mihae Song et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Tim-3: An Emerging Target in the Cancer Immunotherapy Landscape
- (2014) A. C. Anderson Cancer Immunology Research
- An Antibody-Drug Conjugate That Targets Tissue Factor Exhibits Potent Therapeutic Activity against a Broad Range of Solid Tumors
- (2013) E. C. W. Breij et al. CANCER RESEARCH
- Phase II study of temsirolimus (CCI-779) in women with recurrent, unresectable, locally advanced or metastatic carcinoma of the cervix. A trial of the NCIC Clinical Trials Group (NCIC CTG IND 199)
- (2013) A.V. Tinker et al. GYNECOLOGIC ONCOLOGY
- Increased expression of programmed death (PD)-1 and its ligand PD-L1 correlates with impaired cell-mediated immunity in high-risk human papillomavirus-related cervical intraepithelial neoplasia
- (2013) Wen Yang et al. IMMUNOLOGY
- Landscape of genomic alterations in cervical carcinomas
- (2013) Akinyemi I. Ojesina et al. NATURE
- ADXS11-001 immunotherapy targeting HPV-E7: updated survival and safety data from a phase 2 study in Indian women with recurrent/refractory cervical cancer
- (2013) Robert G Petit et al. Journal for ImmunoTherapy of Cancer
- PIK3CA mutational status and overall survival in patients with cervical cancer treated with radical chemoradiotherapy
- (2012) John B. McIntyre et al. GYNECOLOGIC ONCOLOGY
- Lm-LLO-Based Immunotherapies and HPV-Associated Disease
- (2012) Anu Wallecha et al. Journal of Oncology
- Phase II trial of cetuximab in the treatment of persistent or recurrent squamous or non-squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study
- (2011) Alessandro D. Santin et al. GYNECOLOGIC ONCOLOGY
- Survival Data From a Phase II, Open-Label Study of Pazopanib or Lapatinib Monotherapy in Patients With Advanced and Recurrent Cervical Cancer
- (2011) Bradley J. Monk et al. JOURNAL OF CLINICAL ONCOLOGY
- Oligometastases revisited
- (2011) Ralph R. Weichselbaum et al. Nature Reviews Clinical Oncology
- The role of macrophages and mast cells in lymphangiogenesis and angiogenesis in cervical carcinogenesis
- (2010) Dolores Utrera-Barillas et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication
- (2010) Ni Li et al. INTERNATIONAL JOURNAL OF CANCER
- A Phase II Trial of Erlotinib in Recurrent Squamous Cell Carcinoma of the Cervix
- (2010) Russell J. Schilder et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Phase II, Open-Label Study of Pazopanib or Lapatinib Monotherapy Compared With Pazopanib Plus Lapatinib Combination Therapy in Patients With Advanced and Recurrent Cervical Cancer
- (2010) Bradley J. Monk et al. JOURNAL OF CLINICAL ONCOLOGY
- Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study
- (2010) Silvia de Sanjose et al. LANCET ONCOLOGY
- Anti-angiogenesis agents in metastatic or recurrent cervical cancer
- (2009) Bradley J. Monk et al. GYNECOLOGIC ONCOLOGY
- A phase II study of sunitinib in patients with locally advanced or metastatic cervical carcinoma: NCIC CTG Trial IND.184
- (2009) Helen J. Mackay et al. GYNECOLOGIC ONCOLOGY
- Phase III Trial of Four Cisplatin-Containing Doublet Combinations in Stage IVB, Recurrent, or Persistent Cervical Carcinoma: A Gynecologic Oncology Group Study
- (2009) Bradley J. Monk et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial of Bevacizumab in the Treatment of Persistent or Recurrent Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study
- (2009) Bradley J. Monk et al. JOURNAL OF CLINICAL ONCOLOGY
- The first clinical use of a live-attenuated Listeria monocytogenes vaccine: A Phase I safety study of Lm-LLO-E7 in patients with advanced carcinoma of the cervix
- (2009) Paulo Cesar Maciag et al. VACCINE
- Intravaginal Immunization of Mice with Recombinant Salmonella enterica Serovar Typhimurium Expressing Human Papillomavirus Type 16 Antigens as a Potential Route of Vaccination against Cervical Cancer
- (2008) H. Echchannaoui et al. INFECTION AND IMMUNITY
- A phase II trial to evaluate gefitinib as second- or third-line treatment in patients with recurring locoregionally advanced or metastatic cervical cancer
- (2007) A. Goncalves et al. GYNECOLOGIC ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More